Close Menu

NEW YORK (GenomeWeb) – Pennsylvania-based JBS Science said today that it has received a $3 million Small Business Innovation Research Phase IIB Bridge Award from the National Cancer Institute to help commercialize its first liquid biopsy product, a urine DNA screening test for the early detection of hepatocellular carcinoma (HCC).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.